Works matching Tyrosine kinase inhibitors (cancer treatment)

Results: 368
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22

    Evaluation of Drug—Drug Interactions in EGFR-Mutated Non-Small-Cell Lung Cancer Patients during Treatment with Tyrosine-Kinase Inhibitors.

    Published in:
    Journal of Personalized Medicine, 2021, v. 11, n. 5, p. 424, doi. 10.3390/jpm11050424
    By:
    • Occhipinti, Mario;
    • Brambilla, Marta;
    • Galli, Giulia;
    • Manglaviti, Sara;
    • Giammaruco, Maristella;
    • Prelaj, Arsela;
    • Ferrara, Roberto;
    • De Toma, Alessandro;
    • Proto, Claudia;
    • Beninato, Teresa;
    • Zattarin, Emma;
    • Lo Russo, Giuseppe;
    • Gelibter, Alain Jonathan;
    • Simmaco, Maurizio;
    • Preissner, Robert;
    • Garassino, Marina Chiara;
    • De Braud, Filippo;
    • Marchetti, Paolo;
    • Schwab, Matthias
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29

    A multicenter phase II study of TSU-68, a novel oral multiple tyrosine kinase inhibitor, in patients with metastatic breast cancer progressing despite prior treatment with an anthracycline-containing regimen and taxane.

    Published in:
    International Journal of Clinical Oncology, 2013, v. 18, n. 4, p. 590, doi. 10.1007/s10147-012-0421-9
    By:
    • Suzuki, Yasuhiro;
    • Saeki, Toshiaki;
    • Aogi, Kenjiro;
    • Toi, Masakazu;
    • Fujii, Hirofumi;
    • Inoue, Kenichi;
    • Watanabe, Toru;
    • Fujiwara, Yasuhiro;
    • Ito, Yoshinori;
    • Takatsuka, Yuichi;
    • Iwata, Hiroji;
    • Arioka, Hitoshi;
    • Tokuda, Yutaka
    Publication type:
    Article
    30
    31
    32
    33
    34
    35
    36
    37

    Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology.

    Published in:
    Archives of Pathology & Laboratory Medicine, 2018, v. 142, n. 3, p. 321, doi. 10.5858/arpa.2017-0388-CP
    By:
    • Lindeman, Neal I.;
    • Cagle, Philip T.;
    • Aisner, Dara L.;
    • Arcila, Maria E.;
    • Beasley, Mary Beth;
    • Bernicker, Eric H.;
    • Colasacco, Carol;
    • Dacic, Sanja;
    • Hirsch, Fred R.;
    • Kerr, Keith;
    • Kwiatkowski, David J.;
    • Ladanyi, Marc;
    • Nowak, Jan A.;
    • Sholl, Lynette;
    • Temple-Smolkin, Robyn;
    • Solomon, Benjamin;
    • Souter, Lesley H.;
    • Thunnissen, Erik;
    • Ming S. Tsao;
    • Ventura, Christina B.
    Publication type:
    Article
    38
    39
    40

    Mass Spectrometry to Classify Non-Small-Cell Lung Cancer Patients for Clinical Outcome After Treatment With Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Multicohort Cross-Institutional Study.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2007, v. 99, n. 11, p. 838, doi. 10.1093/jnci/djk195
    By:
    • Taguchi, Fumiko;
    • Solomon, Benjamin;
    • Gregorc, Vanesa;
    • Roder, Heinrich;
    • Gray, Robert;
    • Kasahara, Kazuo;
    • Nishio, Makoto;
    • Brahmer, Julie;
    • Spreafico, Anna;
    • Ludovini, Vienna;
    • Massion, Pierre P.;
    • Dziadziuszko, Rafal;
    • Schiller, Joan;
    • Grigorieva, Julia;
    • Tsypin, Maxim;
    • Hunsucker, Stephen W.;
    • Caprioli, Richard;
    • Duncan, Mark W.;
    • Hirsch, Fred R.;
    • Bunn Jr, Paul A.
    Publication type:
    Article
    41
    42
    43

    Detection of EGFR-Activating and T790M Mutations Using Liquid Biopsy in Patients With EGFR-Mutated Non-Small-Cell Lung Cancer Whose Disease Has Progressed During Treatment With First- and Second-Generation Tyrosine Kinase Inhibitors: A Multicenter Real-Life Retrospective Study.

    Published in:
    2020
    By:
    • Minari, Roberta;
    • Mazzaschi, Giulia;
    • Bordi, Paola;
    • Gnetti, Letizia;
    • Alberti, Giorgia;
    • Altimari, Annalisa;
    • Gruppioni, Elisa;
    • Sperandi, Francesca;
    • Parisi, Claudia;
    • Guaitoli, Giorgia;
    • Bettelli, Stefania;
    • Longo, Lucia;
    • Bertolini, Federica;
    • Pagano, Maria;
    • Bonelli, Candida;
    • Tagliavini, Elena;
    • Nicoli, Davide;
    • Ubiali, Alessandro;
    • Zangrandi, Adriano;
    • Trubini, Serena
    Publication type:
    journal article
    44
    45
    46
    47
    48
    49
    50

    Combined stereotactic radiosurgery and tyrosine kinase inhibitor therapy versus tyrosine kinase inhibitor therapy alone for the treatment of non-small cell lung cancer patients with brain metastases.

    Published in:
    Journal of Neurosurgery, 2022, v. 137, n. 2, p. 563, doi. 10.3171/2021.9.JNS211373
    By:
    • Guan-Ying Chiou;
    • Chi-Lu Chiang;
    • Huai-Che Yang;
    • Chia-I Shen;
    • Hsiu-Mei Wu;
    • Yu-Wei Chen;
    • Ching-Jen Chen;
    • Yung-Hung Luo;
    • Yong-Sin Hu;
    • Chung-Jung Lin;
    • Wen-Yuh Chung;
    • Cheng-Ying Shiau;
    • Wan-Yuo Guo;
    • Hung-Chi Pan, David;
    • Cheng-Chia Lee
    Publication type:
    Article